Autologous hematopoietic stem cell transplantation significantly alters circulating ceramides in peripheral blood of relapsing-remitting multiple sclerosis patients

BACKGROUND: The common inflammatory disease multiple sclerosis (MS) is a disease of the central nervous system. For more than 25 years autologous hematopoietic stem cell transplantation (AHSCT) has been used to treat MS. It has been shown to be highly effective in suppressing inflammatory activity i...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaivade, Aina, Wiberg, Anna, Khoonsari, Payam Emami, Carlsson, Henrik, Herman, Stephanie, Al-Grety, Asma, Freyhult, Eva, Olsson-Strömberg, Ulla, Burman, Joachim, Kultima, Kim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327322/
https://www.ncbi.nlm.nih.gov/pubmed/37420217
http://dx.doi.org/10.1186/s12944-023-01863-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327322/
https://www.ncbi.nlm.nih.gov/pubmed/37420217
http://dx.doi.org/10.1186/s12944-023-01863-7

Ejemplares similares